<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02886637</url>
  </required_header>
  <id_info>
    <org_study_id>20160826</org_study_id>
    <nct_id>NCT02886637</nct_id>
  </id_info>
  <brief_title>Effects of Immune Function on Prognositic Outcome in Critical Ill Patients With Acinetobacter Baumannii Infection</brief_title>
  <official_title>Effects of Immune Function on Prognositic Outcome in Critical Ill Patients With Acinetobacter Baumannii Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southeast University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southeast University, China</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the present study is to evaluate the effects of immune function on prognositic&#xD;
      outcome in critical ill patients with Acinetobacter baumannii infection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center, observational study. Patients with Acinetobacter baumannii infection&#xD;
      in the intensive care unit of Zhongda Hospital were enrolled. We recorded the data of age,&#xD;
      ICU admission diagnosis, underlying diseases, APACHE II score and infection site. Body&#xD;
      temperature, heart rate, white blood cell counts, procalcitonin, C-reactive protein, SOFA&#xD;
      score and the level of CD4+, CD8+, Th1, Th2 and HLA-DR in the blood measured by flow&#xD;
      cytometry on the D1, D3 and D7 were also recorded.We can get the results of the change of&#xD;
      immune function of critical ill patients after Acinetobacter baumannii infection. After&#xD;
      compare the patients who die of survive at 28 day after infection, we can get the results of&#xD;
      the relationship between the immune function and the outcome. We also can calculate the&#xD;
      effect immune function on prognositic mortality in patients with Acinetobacter baumannii&#xD;
      infection.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>28 day mortality</measure>
    <time_frame>28 day</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Acinetobacter Baumannii Infection</condition>
  <arm_group>
    <arm_group_label>Acinetobacter baumannii infection</arm_group_label>
    <description>Critically ill patients infect with Acinetobacter baumannii</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>None intervention</intervention_name>
    <arm_group_label>Acinetobacter baumannii infection</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who admitted into ICU and infection with Acinetobacter baumannii.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients admitted to ICU&#xD;
&#xD;
          -  Infection with Acinetobacter baumannii&#xD;
&#xD;
          -  Agree to participate the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age less than 16 years old or older than 80 years old&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  immunosuppression patients which include&#xD;
&#xD;
               1. therapy 0.5mg/kg/day of prednisoneover(equivalent dose of other glucocorticoids)&#xD;
                  for at least 1 month within recent 3 month&#xD;
&#xD;
               2. Cancer chemotherapy within recent 3 month&#xD;
&#xD;
               3. Receive immunosuppression treatment because of solid organ transplant or&#xD;
                  Autoimmune diseases&#xD;
&#xD;
               4. allogeneic bone marrow transplantation or allogeneic haematopoietic stem cell&#xD;
                  transplantation.&#xD;
&#xD;
               5. HIV infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>August 27, 2016</study_first_submitted>
  <study_first_submitted_qc>August 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2016</study_first_posted>
  <last_update_submitted>August 31, 2016</last_update_submitted>
  <last_update_submitted_qc>August 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southeast University, China</investigator_affiliation>
    <investigator_full_name>Jianfeng Xie</investigator_full_name>
    <investigator_title>Attending</investigator_title>
  </responsible_party>
  <keyword>A baumannii infection</keyword>
  <keyword>Immunosuppression</keyword>
  <keyword>prognosis</keyword>
  <keyword>immune function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>we would like to share our data. Someone who need data can contact us with Email.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

